From: Methamphetamine-induced changes in myocardial gene transcription are sex-dependent
Ensembl Identification | symbol | Gene Name | Saline FPKM | Meth FPKM | Effect (Fold up/ down) | Padj |
---|---|---|---|---|---|---|
ENSRNOG00000021027 | Dbp* | D-site binding protein | 8.2 ± 3.7 | 76.4 ± 31 | 9.3 Up | 2.1 E-05 |
ENSRNOG00000050675 | Myl4 | Myosin Light Chain 4 | 4.6 ± 1.9 | 37.4 ± 17 | 8.2 Down | 0.00024 |
ENSRNOG00000018413 | Per3* | Period Circadian Regulator 3 | 2.1 ± 0.9 | 17.3 ± 7.1 | 8.2 Up | 9.3 E-06 |
ENSRNOG00000020254 | Per2* | Period Circadian Regulator 2 | 3.3 ± 1.5 | 20.3 ± 8.3 | 6.1 Up | 4.0 E-05 |
ENSRNOG00000014448 | Bmal1 / Arntl* | Aryl hydrocarbon receptor nuclear translocator-like protein 1 | 21.9 ± 9.8 | 3.9 ± 1.6 | 5.6 Down | 0.019 |
ENSRNOG00000013408 | Npas2* | Neuronal PAS domain protein 2 | 7.3 ± 3.3 | 1.7 ± 0.7 | 4.3 Down | 0.0013 |
ENSRNOG00000000633 | Rhobtb1 | Rho Related BTB Domain Containing 1 | 8.7 ± 3.9 | 37.2 ± 15.2 | 4.3 Up | 5.9E-06 |
ENSRNOG00000006033 | Spon2 | Spondin 2 | 8.3 ± 3.7 | 2 ± 0.8 | 4.2 Down | 7.5E-05 |
ENSRNOG00000029980 | Zbtb16 | Zinc Finger and BTB Domain containing 16 | 4.8 ± 2.1 | 18.7 ± 7.6 | 3.9 Up | 0.00033 |
ENSRNOG00000019383 | Tef | Thyrotroph embryonic factor | 18 ± 8 | 62.4 ± 25.5 | 3.5 Up | 8.8E-06 |
ENSRNOG00000020525 | Col5a3 | Collagen type V Alpha 3 chain | 13.5 ± 6 | 4 ± 1.6 | 3.4 Down | 5.9E-06 |
ENSRNOG00000001469 | Eln | Elastin | 45 ± 20 | 14 ± 5.7 | 3.2 Down | 2.1E-05 |
ENSRNOG00000045821 | Slc41a3 | Solute carrier Family 41 Member 3 | 57.2 ± 25.6 | 19.3 ± 7.9 | 2.963 Down | 0.00017 |
ENSRNOG00000046912 | Nr1d2 | Nuclear receptor subfamily 1, group D, member 2 | 11.1 ± 5 | 30.5 ± 12.4 | 2.7 Up | 0.00017 |
ENSRNOG00000010947 | Mmp14 | Matrix metallopeptidase 14 | 22.9 ± 10.2 | 8.4 ± 3.4 | 2.7 Down | 1.2E-05 |
ENSRNOG00000003515 | Ephx1 | Epoxide hydrolase 1 | 7.5 ± 3.3 | 20.2 ± 8.3 | 2.7 Up | 1.5E-05 |
ENSRNOG00000060511 | NA | Neuraminidase | 8.8 ± 3.9 | 23.3 ± 9.5 | 2.6 Up | 2.9E-05 |
ENSRNOG00000049422 | Fcgr2a | Fc fragment of IgG receptor II a | 6.5 ± 2.9 | 2.5 ± 1 | 2.6 Down | 0.0026 |
ENSRNOG00000000521 | Cdkn1a | Cyclin dependent kinase inhibitor 1A | 31.8 ± 14.2 | 12.2 ± 5 | 2.6 Down | 0.00089 |
ENSRNOG00000046663 | Fcgr2a | Fc fragment of IgG receptor II a | 11.6 ± 5.2 | 4.5 ± 1.8 | 2.6 Down | 0.0015 |
ENSRNOG00000056153 | Fam46b | Family with sequence similarity 46, member B | 4.8 ± 2.1 | 11.9 ± 4.9 | 2.5 Up | 0.018 |
ENSRNOG00000000885 | LOC100362819 | 8.9 ± 4 | 3.6 ± 1.5 | 2.5 Down | 0.00024 | |
ENSRNOG00000001414 | Serpin E1 | Endothelial plasminogen activator inhibitor-1 | 7.2 ± 3.2 | 17.3 ± 7.1 | 2.4 Up | 5.5E-05 |
ENSRNOG00000029810 | Tspan4 | Tetraspanin-4 | 12.1 ± 5.4 | 29.2 ± 11.9 | 2.4Up | 0.00053 |
ENSRNOG00000055564 | RGD1564664 | 9.5 ± 4.2 | 4.1 ± 1.7 | 2.3 Down | 0.0019 | |
ENSRNOG00000017716 | Ucp3 | Mitochondrial uncoupling protein 3 | 10.5 ± 4.7 | 4.6 ± 1.9 | 2.3 Down | 0.014 |
ENSRNOG00000049324 | LOC100911766 | 5.5 ± 2.5 | 12.4 ± 5.1 | 2.3 Up | 0.0005 | |
ENSRNOG00000008680 | Loxl1 | Lysyl oxidase homolog 1 | 14.9 ± 6.7 | 6.7 ± 2.7 | 2.2 Down | 8.6E-05 |
ENSRNOG00000058500 | LOC103694908 | 10.7 ± 4.8 | 4.9 ± 2.0 | 2.2 Down | 0.015 | |
ENSRNOG00000000906 | Medag | Mesenteric estrogen dependent adipogenesis | 20 ± 9 | 9.3 ± 3.8 | 2.2 Down | 7.3E-05 |
ENSRNOG00000011800 | F3 | Platelet tissue factor | 5.5 ± 2.5 | 12 ± 5 | 2.2 Up | 0.001 |
ENSRNOG00000004699 | Fibin | Fin Bud Initiation Factor Homolog | 9.4 ± 4.2 | 4.4 ± 1.8 | 2.1 Down | 0.0007 |
ENSRNOG00000003228 | Mid1ip1 | MID 1 Interacting Protein 1 | 31.6 ± 14.1 | 67.7 ± 27.6 | 2.1 Up | 7.6E-06 |
ENSRNOG00000006663 | Usp2 | Ubiquitin Specific Peptidase 2 | 14.2 ± 6.3 | 30.1 ± 12.3 | 2.1 Up | 0.015 |
ENSRNOG00000016573 | Dgat2 | Diacylglycerol O-Acyltransferase 2 | 5.8 ± 2.6 | 12.1 ± 5 | 2.1 Up | 0.0019 |
ENSRNOG00000005271 | Rapgef5 | Rap guanine nucleotide exchange factor 5 | 8.8 ± 3.9 | 17.6 ± 7.2 | 2.0 Up | 1.2E-05 |